Literature DB >> 9799201

Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability.

R Kornowski1, M K Hong, M B Leon.   

Abstract

BACKGROUND: A novel 3-dimensional left ventricular (LV) mapping system uses low-intensity magnetic field energy to determine the location of sensor-tipped electrode catheters within the LV. Using this system, we sought to distinguish between infarcted, ischemic, and normal myocardium by comparing LV electromechanical mapping data with myocardial perfusion imaging studies. METHODS AND
RESULTS: Unipolar voltage potentials and local endocardial shortening (LS) were measured in 18 patients (mean age, 58+/-12 years) with symptomatic chronic angina having reversible and/or fixed myocardial perfusion defects on single photon emission computed tomography imaging studies using 201Tl at rest and 99mTc-sestamibi after adenosine stress. Overall, a significant difference in voltage potentials and LS values was found between groups (P<0.001 for each comparison by ANOVA). The average voltage potentials (14.0+/-2.0 mV) and LS values (12.5+/-2.8%) were highest when measured in myocardial segments (n=56) with normal perfusion and lowest (7.5+/-3.4 mV and 3.4+/-3.4%) when measured in myocardial segments with fixed perfusion defects (n=20) (P<0.0001). Myocardial segments with reversible perfusion defects (n=66) had intermediate voltage amplitudes (12.0+/-2.8 mV, P=0.048 versus normal and P=0.005 versus fixed segments) and LS values (10.3+/-3.7%, P=0.067 versus normal and P=0.001 versus fixed segments).
CONCLUSIONS: In patients with myocardial ischemia, LV mapping, compared with myocardial perfusion imaging, shows (1) mild reduction of endocardial voltage potentials and LS in segments with reversible perfusion defects and (2) profound electromechanical impairment in segments with fixed perfusion defects. Thus, such an LV mapping procedure may allow the detection on-line of myocardial viability in the catheterization laboratory.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799201     DOI: 10.1161/01.cir.98.18.1837

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Left ventricular electromechanical mapping: a case study of functional assessment in coronary intervention.

Authors:  E C Perin; G V Silva; R Sarmento-Leite
Journal:  Tex Heart Inst J       Date:  2000

Review 2.  Recent advances in cardiac mapping techniques.

Authors:  C Schmitt; G Ndrepepa; I Deisenhofer; M Schneider
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 3.  Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.

Authors:  Peter J Psaltis; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2008-12-10       Impact factor: 4.132

Review 4.  Intramyocardial navigation and mapping for stem cell delivery.

Authors:  Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-23       Impact factor: 4.132

5.  Validation of QwikStar Catheter for left ventricular electromechanical mapping with NOGA XP system.

Authors:  Marlos R Fernandes; Guilherme V Silva; Yi Zheng; Edie M Oliveira; Cristiano O Cardoso; John Canales; Ricardo Sanz-Ruiz; Pilar Jimenez-Quevedo; Fred Baimbridge; Emerson C Perin
Journal:  Tex Heart Inst J       Date:  2008

6.  Validation of transcatheter left ventricular electromechanical mapping for assessment of cardiac function and targeted transendocardial injection in a porcine ischemia-reperfusion model.

Authors:  Sharven Taghavi; Jason M Duran; Remus M Berretta; Catherine A Makarewich; Foram Udeshi; Thomas E Sharp; Hajime Kubo; Steven R Houser; Jon C George
Journal:  Am J Transl Res       Date:  2012-04-18       Impact factor: 4.060

Review 7.  The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations.

Authors:  Timm Dickfeld; Christopher Kocher
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

8.  Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Authors:  Douglas W Losordo; Timothy D Henry; Charles Davidson; Joon Sup Lee; Marco A Costa; Theodore Bass; Farrell Mendelsohn; F David Fortuin; Carl J Pepine; Jay H Traverse; David Amrani; Bruce M Ewenstein; Norbert Riedel; Kenneth Story; Kerry Barker; Thomas J Povsic; Robert A Harrington; Richard A Schatz
Journal:  Circ Res       Date:  2011-07-07       Impact factor: 17.367

9.  Characterisation of acute myocardial ischaemia in a canine model based on principal component analysis of unipolar endocardial electrograms.

Authors:  A Schwartzman; T Wolf; L Gepstein; G Hayam; J Lessick; D Reisfeld; Y Schwartz; G Uretzky; S A Ben-Haim
Journal:  Med Biol Eng Comput       Date:  2001-09       Impact factor: 2.602

Review 10.  Cardiac gene therapy: are we there yet?

Authors:  P N Matkar; H Leong-Poi; K K Singh
Journal:  Gene Ther       Date:  2016-04-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.